This updated second edition of the book is thoroughly revised to encompass all the latest significant findings from 2017 to 2024. Designed for a postgraduate audience, it features a well-structured format with a synopsis at the conclusion of each chapter. This comprehensive resource delivers an up-to-date examination of risk factors and genetic influences linked to the development of male breast cancer (MBC).
Inside this volume, readers will find a detailed analysis of clinical features alongside recent advances in histopathology and molecular profiling, serving as an essential guide for clinicians to customize treatment plans for individual patients and their tumors. The book reveals critical insights into effective strategies for diagnosing or ruling out MBC, making it a timely addition to the field.
Moreover, it addresses the psychological needs of men diagnosed with breast cancer and explores the most effective support methods available. The surgical management of the disease is discussed in depth, including algorithms for local and systemic therapy. Given the challenges posed by late diagnosis in MBC, many patients present with advanced or disseminated disease, and this edition reviews evidence-based management strategies for these cases.
Finally, Male Breast Cancer concludes with a focus on prognosis determination and anticipated future developments, emphasizing improvements in diagnosis and patient survival. This book is a vital resource for breast surgeons, oncologists, breast radiologists, histopathologists, and breast care nurses around the globe. It serves as an invaluable reference for all pertinent information related to male breast cancer.
